STEPHANIE WITTKOETTER: Open Payments
NPI 1568172260 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 48 payments from 15 companies in 2025. Trend: 2023 $602 · 2024 $584 · 2025 $926
Food & beverage: $926
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $266 |
| Novo Nordisk Inc | 7 | $156 |
| Lilly USA, LLC | 5 | $121 |
| PFIZER INC. | 3 | $52 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Exact Sciences Corporation | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
Products named: VRAYLAR, Wegovy, UBRELVY, JARDIANCE, MOUNJARO, SHINGRIX, Ozempic, CAPLYTA.
Industry payments across MO — which companies pay providers there.
